
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
In this review of the month of October, HCPLive highlights some of the most significant dermatology news updates.
October 2025 saw a wide array of developments in the






